1005 related articles for article (PubMed ID: 12224000)
1. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.
Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O
Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943
[TBL] [Abstract][Full Text] [Related]
3. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
4. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
[TBL] [Abstract][Full Text] [Related]
5. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
6. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
Schwartz J; Leber MD; Gillis S; Giunta A; Eldor A; Bussel JB
Am J Hematol; 2003 Feb; 72(2):94-8. PubMed ID: 12555211
[TBL] [Abstract][Full Text] [Related]
7. Outcome of chronic idiopathic thrombocytopenic purpura in children.
Bansal D; Bhamare TA; Trehan A; Ahluwalia J; Varma N; Marwaha RK
Pediatr Blood Cancer; 2010 Mar; 54(3):403-7. PubMed ID: 19908301
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
[TBL] [Abstract][Full Text] [Related]
9. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
[TBL] [Abstract][Full Text] [Related]
11. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Schweizer C; Reu FJ; Ho AD; Hensel M
Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
[TBL] [Abstract][Full Text] [Related]
12. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
[TBL] [Abstract][Full Text] [Related]
13. Recurrent immune thrombocytopenic purpura in children.
Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Pediatr Hematol Oncol; 2006 Dec; 23(8):677-82. PubMed ID: 17065144
[TBL] [Abstract][Full Text] [Related]
14. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
[TBL] [Abstract][Full Text] [Related]
15. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat.
Rodeghiero F
Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569
[TBL] [Abstract][Full Text] [Related]
16. Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.
Zhou H; Fu R; Wang H; Zhou F; Li H; Zhou Z; Zhang L; Yang R
Ann Hematol; 2013 Jan; 92(1):79-87. PubMed ID: 22956151
[TBL] [Abstract][Full Text] [Related]
17. A follow-up study of 49 adult patients with idiopathic thrombocytopenic purpura treated with high-dose immunoglobulins and anti-D immunoglobulins.
Rodeghiero F; Schiavotto C; Castaman G; Vespignani M; Ruggeri M; Dini E
Haematologica; 1992; 77(3):248-52. PubMed ID: 1330848
[TBL] [Abstract][Full Text] [Related]
18. Durability and factors associated with long term response after splenectomy for primary immune thrombocytopenia (ITP) and outcome of relapsed or refractory patients.
Aleem A
Platelets; 2011; 22(1):1-7. PubMed ID: 20964585
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
[TBL] [Abstract][Full Text] [Related]
20. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M
Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]